JCCT is conducting clinical research studies for adults interested in helping advance treatments for gastrointestinal and central nervous system (CNS) conditions. Eligibility varies by study. Complete the form below to learn about current research opportunities that may be right for you.
JCCT is conducting clinical research studies for adults interested in helping advance treatments for chronic kidney disease and other nephrology conditions. Eligibility varies by study. Complete the form below to learn about current research opportunities that may be right for you.
JCCT is conducting cardiovascular and cardiometabolic clinical research studies for adults interested in helping advance treatments for heart and metabolic conditions. Eligibility varies by study. Complete the form below to learn about current research opportunities that may be right for you.
JCCT is conducting clinical research studies for adults interested in helping advance treatments for obesity, GLP-1 therapies, metabolic disorders, and endocrine conditions. Eligibility varies by study. Complete the form below to learn about current opportunities that may be right for you.
JCCT is conducting vaccine clinical research studies for adults interested in helping advance the prevention of infectious diseases. Eligibility varies by study. Complete the form below to learn about current vaccine research opportunities that may be right for you.
The purpose of this study is to evaluate an investigational medication designed to break down the harmful antibodies that cause Graves’ Disease and target the root cause of the condition, which may help treat the disease without the common side effects of standard medications and also may help protect the thyroid gland.
The purpose of this research is to evaluate in gout patients who have been taking allopurinol regularly, how will addition of an investigational drug ABP-671 affects how allopurinol and its active substance (oxypurinol) are absorbed and metabolized in the body.
We are doing this study to learn more about the benefits and safety of treatment of an experimental drug called baxdrostat in combination with dapagliflozin for treating patients with CKD and high blood pressure. We also want to better understand CKD and the health problems that come with it.
The purpose of this study is to find out if the study vaccine is safe and how your immune system responds to it.
